An overview of the latest issue of Angewandte Chemie
Angewandte Chemie 21/2012: One Step Ahead
New Route to Aminohydantoins
The hydantoin scaffold found in a range of drugs can be formed simply from ureas and thioureas tethered to amides
Angewandte Chemie 20/2012: A Trip through the World of Chemistry
An overview of the latest issue of Angewandte Chemie
Not All Prions Are Destructive
Japanese reseachers show that prions can contribute to drug resistance and cellular adaptation
Ranbaxy Launches Anti-Malaria Drug
India’s first new drug; first recently developed antimalarial not based on artemisinin
The Future of Medicinal Chemistry
T. Hoffmann and R. Metternich, F. Hoffmann−La Roche Ltd., look at potential areas for drug R&D outside traditional medicinal chemistry
Angewandte Chemie 19/2012: The Secret of Print
An overview of the latest issue of Angewandte Chemie
Combatting Designer Drugs Head On
New methods to help law enforcement keep up with the dizzying array of new designer drugs designed to escape detection
Thomas Scheuring on Organizing the ACHEMA Exhibition
T. Scheuring, CEO of DECHEMA Ausstellungs-GmbH, talks about what DECHEMA's reorganization means for the upcoming ACHEMA
Model Predicts Nanoparticle Toxicity
Model predicts toxicity of metal oxide nanoparticles based on electrical and solublity properties